2008 News

December 22, 2008

Morphotek Inc. Announces Research Agreement with The University of Pennsylvania to Develop Oncology Therapeutic Antibody Candidates
Read More

November 20, 2008

Morphotek, Inc. Receives Additional $1.6M in Funding from The U.S. Department of Defense to Develop Therapeutic Antibodies Against Microbial Bioweapons
Read More

September 25, 2008

Morphotek, Inc. and Pivotal BioSciences Announce Agreement for the Development of Therapeutic Monoclonal Antibodies
Read More

August 13, 2008

Morphotek, Inc. Announces License Agreement for the Development of a Monoclonal Antibody to Treat Prostate Cancer
Read More

July 21, 2008

Morphotek Executive, Rodney Dausch, Named Small Company CFO of the Year in the Greater Philadelphia Region
Read More

June 17, 2008

Morphotek, Inc. Receives $1.7M in Funding from the U.S. Department of Defense to Develop Therapeutic Antibodies Against Microbial Bioweapons
Read More

May 21, 2008

Morphotek Announces Collaboration to Facilitate Development of Human Monoclonal Antibodies for the Treatment or Prophylaxis of Infectious Disease
Read More

March 6, 2008

Morphotek Signs Exclusive Licensing Agreement for Anti-Cancer Antibody
Read More

January 16, 2008

Morphotek Announces Collaborative Research Agreement with Ludwig Institute for Cancer Research
Read More

January 9, 2008

Morphotek Announces Agreement for the Development of Antibodies to Treat Prostate Cancer
Read More